Observational studyBMC cancer2024

International multicenter real-world REGistry for patients with metastatic renAL cell carcinoma - Meet-URO 33 study (REGAL study).

Sara Elena Rebuzzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.